CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 14 enrolled
Drug / intervention
colchicine tablets +1 moredrug
Likely dose
colchicine tablets 0.6mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01017003
NCT01017003Phase 1Completed

An Open Label, Two Period, Sequential, Single Dose and Multiple Dose Pharmacokinetic Study With 0.6mg Colchicine Tablets in Healthy Volunteers

Mutual Pharmaceutical Company, Inc.·interventional·Posted Nov 20, 2009·Updated Nov 20, 2009

In Brief

A Phase 1 clinical trial evaluating colchicine tablets for Pharmacokinetics. Completed, enrolled 14 participants across 1 site.

Detailed Summary

This open label, single group, sequential dose study will compare the single dose pharmacokinetics of colchicine 0.6 mg given orally to colchicine pharmacokinetics after 10 days of a standard prophylactic dose (0.6 mg every 12 hours) in healthy volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 20, 2009
Enrollment StartSep 1, 2007
Primary CompletionOct 1, 2007
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.6 years ago

Interventions

colchicine tabletsdrug

0.6mg colchicine tablet

colchicine tabletsdrug

0.6mg q12 hours for 10 days